| Vol. 1.19 – 19 November, 2020 |
| |
|
|
| Researchers found that shape change was regulated by a β-catenin-mediated decrease in RhoA activity and subsequent decrease in the plasma membrane tension. Preventing a decrease in membrane tension resulted in early differentiation defects in ESCs and gastruloids. [Cell Stem Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors established a screening strategy to identify drugs that reduce angiotensin converting enzyme 2 levels in human ESC-derived cardiac cells and lung organoids. [Cell Stem Cell] |
|
|
|
| Researchers demonstrated that ACE2‐Fc could specifically abrogate virus replication by blocking the entry of SARS‐CoV‐2 spike‐expressing pseudotyped virus into both ACE2‐expressing lung cells and lung organoids. [EMBO Molecular Medicine] |
|
|
|
| Scientists investigated the additive effect of combination therapy using remdesivir with recombinant soluble ACE2 on Vero E6 and kidney organoids, targeting two different modalities of SARS‐CoV‐2 life cycle: cell entry via its receptor ACE2 and intracellular viral RNA replication. [EMBO Molecular Medicine] |
|
|
|
| Investigators showed that the upregulation of SOX2 was central to cancer-associated fibroblasts (CAFs) promoting tumor malignancy, which was repressed by protein kinase Cζ (PKCζ). PKCζ deficiency activated the reprogramming of colonic fibroblasts to generate a predominant SOX2-dependent CAF population expressing the WNT regulator Sfrp2 as its top biomarker. [Developmental Cell] |
|
|
|
| Scientists revealed reduced reactivity of the astrocytic glial fibrillary acidic protein in the degenerated substantia nigra of PRKN-mutated patients, as well as in midbrain organoids generated from iPSCs reprogramed from PRKN-mutated patient fibroblasts. [npj Parkinson’s Disease] |
|
|
|
| Researchers describe a fully defined feeder-free protocol to generate early testis-like cells with the ability to be cultured as an organoid, from human induced pluripotent stem cells. [Stem Cell Reports] |
|
|
|
| Organoid-derived CD44(−) cancer cells were capable of organoid re-formation and could be re-programed as CD44-expressing cancer-initiating cells in the organoid culture system. [Cancer Letters] |
|
|
|
| An Hsp90 inhibitor, 17-AAG, significantly suppressed MERS-CoV propagation in cell lines and physiological-relevant human intestinal organoids. [Emerging Microbes & Infections] |
|
|
|
| Researchers generated an isogenic mutant in the general stress response sigma factor RpoS and employed this mutant to compare challenges faced by a bacterium during colonization of the human intestinal organoids lumen relative to the germ-free mouse intestine. [mSphere] |
|
|
|
| To create a model system of these cartilage-bone interactions, researchers developed an osteochondral organoid from murine induced pluripotent stem cells. They grew organoids from a single cell type through time-dependent sequential exposure of growth factors to mirror bone development through endochondral ossification. [Tissue Engineering] |
|
|
|
|
| The authors underline the need for providing engineering solutions to gain control of self-organization and functionality of human PSC-derived organoids. [Nature Materials] |
|
|
|
| Novel bioengineered models, organoid systems, and microfabrication technologies, such as 3D bioprinting, have delivered key innovations towards more advanced platforms for tumor modeling in vitro. [Trends in Cancer] |
|
|
|
| Scientists review the recent portfolios of primary tissue-derived and PSC-derived organoids in the digestive systems. They also discuss the promise and challenges in disease modeling and drug development applications for digestive disorders. [Cell Death & Differentiation] |
|
|
|
|
| Proteintech and HebeCell announced their collaborative partnership to develop proprietary nanobody based chimeric antigen receptor technology for the development and commercialization of iPSC-derived natural killer cells, a promising cellular immunotherapy treatment for cancer and other diseases. [Proteintech] |
|
|
|
|
| March 17 – March 19, 2021 Virtual |
|
|
|
|
|
| Ncardia – Share Gosselies, Belgium |
|
|
|
| New York Blood Center – New York, New York, United States |
|
|
|
| Columbia University Medical Center – New York, New York, United States |
|
|
|
| Columbia University Medical Center – New York, New York, United States |
|
|
|
| Albert Einstein College of Medicine – New York, New York, United States |
|
|
|
|